Company intelligence / Profile preview

ViralClear Pharmaceuticals, Inc.

Westport, Connecticut, United Statesbiosig.com ↗

Ownership: Public · BSGM
Development stage: Phase 2

Overview

ViralClear Pharmaceuticals developed merimepodib (Vicromax), an orally administered small-molecule antiviral targeting IMPDH. The drug showed strong preclinical activity against SARS-CoV‑2 and had a robust safety record from previous development programs. By mid–2020 the company initiated Phase II clinical trials for hospitalized COVID‑19 patients at Mayo Clinic sites. Merimepodib was also studied in combination with remdesivir to enhance antiviral effects. The company leveraged US-based CDMOs like Catalent and AMRI for manufacturing support. As of late 2020/early 2021, no commercial approval had been reported.

Therapeutic areas: Infectious Diseases
Modalities: Small molecules
Industry: Biotech

Drug pipeline

1 asset

merimepodib

Phase 2

Indications: COVID-19

Partnerships

Albany Molecular Research Inc. (AMRI) – API manufacturing partnerCatalent – oral formulation development/manufacturing partnerMayo Clinic – clinical trial site/collaborator for Phase II study led by Dr. Andrew D. Badley

Beyond the preview

Go deeper on ViralClear Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViralClear Pharmaceuticals, Inc..

Explore the full profile